ArticleHuman vaccines & immunotherapeutics2018
Impact of European vaccination policies on seasonal influenza vaccination coverage rates: An update seven years later.
Article in Human vaccines & immunotherapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 29 citations in OpenAlex.
- How to boost the boosters? A survey-experiment on the effectiveness of different policies aimed at enhancing acceptance of a "Seasonal" vaccination against COVID-19.Israel journal of health policy research · 2022Trial
- Influenza Vaccination in Spain: Understanding the Impact of Suboptimal Coverage on Health, Society, and the Economy.Vaccines · 2026Review
- Disentangling behavioral determinants of seasonal influenza vaccination in post-corona era: An integrated model approach.PloS one · 2025Article
- The impact of the COVID-19 pandemic and the free vaccination policy on seasonal influenza vaccination uptake among older adults in Ningbo, Eastern China.Human vaccines & immunotherapeutics · 2024Article
- Role of new vaccinators/pharmacists in life-course vaccination.Annals of medicine · 2024Review
- Uptake and correlates of influenza vaccine among older adults residing in rural regions of south China: a cross-sectional study.Frontiers in public health · 2024Article
- A review of factors influencing vaccination policies and programs for older adults globally.Human vaccines & immunotherapeutics · 2023Review
- Influenza Vaccination Coverage Rates and Determinants in Greek Children until the Age of Ten (2008-2019), the Rhea Mother-Child Cohort.Vaccines · 2023Article
- Cluster randomized trial of influenza vaccination in patients with acute heart failure in China: A mixed-methods feasibility study.PLOS global public health · 2023Article
- Factors influencing healthcare professionals' confidence in vaccination in Europe: a literature review.Human vaccines & immunotherapeutics · 2022Review
- The estimated age-group specific influenza vaccine coverage rates in Hong Kong and the impact of the school outreach vaccination program.Human vaccines & immunotherapeutics · 2022Article
- Article
- Comparison of influenza surveillance systems in Australia, China, Malaysia and expert recommendations for influenza control.BMC public health · 2021Article
- Trends in influenza coverage rates in five consecutive immunisation seasons in the Local Health Unit of Ferrara (North Italy).Journal of preventive medicine and hygiene · 2021Article
- [Current recommendations for vaccination in older adults].MMW Fortschritte der Medizin · 2021Article
- Factors associated with parental acceptance of influenza vaccination for their children: the evidence from four cities of China.Human vaccines & immunotherapeutics · 2021Article
- The importance of confidence, complacency, and convenience for influenza vaccination among key risk groups in large urban areas of Peru.Human vaccines & immunotherapeutics · 2021Article
- Factors driving choices between types and brands of influenza vaccines in general practice in Austria, Italy, Spain and the UK.PloS one · 2021Article
- Key policy and programmatic factors to improve influenza vaccination rates based on the experience from four high-performing countries.Drugs in context · 2021Review
- Influenza vaccine and cardiac protection: a study from a tertiary care center.Human vaccines & immunotherapeutics · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 9 institutions in 9 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Seasonal influenza can have serious morbid consequences and can even result in death, particularly in at-risk populations, including healthcare professionals (HCPs), elderly and those living with a medical risk condition. Although in Europe recommendations exist for annual influenza vaccination in these populations in most countries, the vaccination coverage rate (VCR) is often well below the World Health Organization target of 75% coverage. In our previous survey in 2009 we showed that some elements of national vaccination policies, e.g. reminder systems, strong official recommendation, and easy access, seemed to contribute to achieving higher influenza VCRs among elderly. We repeated the survey in 2016, using the same methodology to assess changes in influenza VCRs among the elderly and in the impact of policy elements on these VCRs. In addition, we collected information about VCRs among HCPs, and those living with a medical risk condition. The median VCR in the 21 countries that had recommendations for influenza vaccination in the elderly was 35.3%, ranging from 1.1% in Estonia to 74.5% in Scotland. The average VCRs for HCPs and those living with medical risk conditions, available in 17 and 10 countries, respectively, were 28.3% (range 7% in Czech Republic to 59.1% in Portugal) and 32.2% (range from 20.0% in the Czech Republic and Hungary to 59.6% in Portugal), respectively. Fewer countries were able to provide data from HCP and those living with medical risk conditions. Since the initial survey during the 2007-2008 influenza season, VCRs have decreased in the elderly in the majority of countries, thus, achieving high VCRs in the elderly and the other target groups is still a major public health challenge in Europe. This could be addressed by the identification, assessment and sharing of best practice for influenza vaccination policies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.